Atypical hemolytic uremic syndrome.
The pathogenesis of atypical uremic syndrome (HUS), which is rarely encountered in childhood, is poorly understood and its mortality and morbidity rates are high. A wide variety of therapeutic approaches has been attempted and the literature contains numerous conflicting reports about the results of these approaches. In a case diagnosed as recurrent atypical HUS, pulse methyl prednisolone, fresh frozen plasma infusions and plasma exchange transfusion were used at different stages of the disease with satisfactory response.
Kavukçu
S
S
Department of Pediatrics, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.
Irken
G
G
Olgun
N
N
Güçlü
A
A
D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000628:therapy*; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage; D010951:Plasma Exchange
D008775:Methylprednisolone